Immuneering CorporationIMRXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+21.0%
5Y CAGR+28.2%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+21.0%/yr
Annual compound
5Y CAGR
+28.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$128.65M+255.9%
2024$36.14M-39.2%
2023$59.41M-18.2%
2022$72.64M-3.0%
2021$74.89M+101.9%
2020$37.09M+169.1%
2019$13.78M-